SELP and metastatic malignant neoplasm: In addition to increased aggregation profiles, we demonstrate that platelets in patients with metastatic cancer are significantly more reactive to ADP, ADP/epinephrine, and TRAP, as determined by P-selectin expression (Fig. 2).